scispace - formally typeset
Search or ask a question
Institution

National Jewish Health

HealthcareDenver, Colorado, United States
About: National Jewish Health is a healthcare organization based out in Denver, Colorado, United States. It is known for research contribution in the topics: T cell & Asthma. The organization has 883 authors who have published 833 publications receiving 79201 citations. The organization is also known as: National Jewish Medical and Research Center.
Topics: T cell, Asthma, Population, Lung, Antigen


Papers
More filters
Journal ArticleDOI
TL;DR: Analysis of data from 2 multinational, randomized, double-blind, placebo-controlled clinical trials designed to evaluate ragweed SLIT-T efficacy and safety in adults with ragweed pollen-induced allergic rhinitis with or without conjunctivitis, found that the former is more beneficial than the latter.
Abstract: Background Efficacy of standardized short ragweed sublingual immunotherapy tablet (SLIT-T), MK-3641 (Merck/ALK; 12 Amb a 1-U of Ambrosia artemisiifolia) treatment on Canadian ragweed-allergic subjects was assessed using subgroup analysis of data from 2 multinational, randomized, double-blind, placebo-controlled clinical trials designed to evaluate ragweed SLIT-T efficacy and safety in adults with ragweed pollen-induced allergic rhinitis with or without conjunctivitis (AR/C), with or without asthma.

1 citations

Patent
10 Nov 2011
TL;DR: In this paper, methods to treat allergic conditions, including pulmonary and non-pulmonary conditions, in a subject by administering a composition that inhibits Pim kinase were described. But none of these methods were applied to the human subjects.
Abstract: Disclosed are methods to treat allergic conditions, including pulmonary and non-pulmonary conditions, in a subject by administering a composition that inhibits Pim kinase. Also disclosed are methods to treat allergic conditions in a subject by administering a composition that induces expression of Runx3.

1 citations

Book ChapterDOI
01 Jan 2015
TL;DR: The goal of immunosuppressive (IS) therapy in cardiac sarcoidosis is to reverse any ongoing active granulomatous myocarditis, potentially prevent progression of myocardial granulOMatous inflammation to scar tissue, and reduce or prevent the development of serious or life threatening cardiac complications.
Abstract: Sarcoidosis is a multi-system granulomatous disorder of yet unknown etiology that predominantly involves the lungs in over 90 % of cases but can also involve any organ in the body. Cardiac sarcoidosis is detected clinically in about 5 % of patients with sarcoidosis but on autopsy in as many as 40 % suggesting that the majority of cases may be underdiagnosed. Complications of cardiac sarcoidosis can include ventricular dysfunction, conduction abnormalities, ventricular arrhythmias and sudden cardiac death. These may occur suddenly, without warning in a previously asymptomatic or undiagnosed patient. There are currently no guidelines on how to definitively manage cardiac sarcoidosis. The goal of immunosuppressive (IS) therapy in cardiac sarcoidosis is to reverse any ongoing active granulomatous myocarditis, potentially prevent progression of myocardial granulomatous inflammation to scar tissue, and reduce or prevent the development of serious or life threatening cardiac complications. Management of cardiac sarcoidosis requires the collaborative effort of a sarcoidosis expert, an electrophysiologist, and a general cardiologist.

1 citations


Authors

Showing all 901 results

NameH-indexPapersCitations
Thomas V. Colby12650160130
John W. Kappler12246457541
Donald Y.M. Leung12161450873
Philippa Marrack12041654345
Jeffrey M. Drazen11769352493
Peter M. Henson11236954246
David A. Schwartz11095853533
David A. Lynch10871459678
Norman R. Pace10129750252
Kevin K. Brown10038747219
Stanley J. Szefler9955437481
Erwin W. Gelfand9967536059
James D. Crapo9847337510
Yang Xin Fu9739033526
Stephen D. Miller9443330499
Network Information
Related Institutions (5)
National Institutes of Health
297.8K papers, 21.3M citations

91% related

Johns Hopkins University School of Medicine
79.2K papers, 4.7M citations

91% related

University of Texas Southwestern Medical Center
75.2K papers, 4.4M citations

91% related

Baylor College of Medicine
94.8K papers, 5M citations

91% related

Icahn School of Medicine at Mount Sinai
76K papers, 3.7M citations

90% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20233
202214
202113
202017
201917
201841